Targeting interleukin-1 in heart failure and inflammatory heart disease.
about
Looking for Pyroptosis-Modulating miRNAs as a Therapeutic Target for Improving Myocardium SurvivalDeletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.Differential Regulation of Cardiac Function and Intracardiac Cytokines by Rapamycin in Healthy and Diabetic Rats.Immune-mediated mechanisms of atherosclerosis and implications for the clinic.Interleukin-1 Blockade for the Treatment of Pericarditis.Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation:Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2).Role of cardiac inflammation in right ventricular failure.Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction.Blood-borne Interleukin-1β Acts upon the Subfornical Organ to Upregulate the Sympathoexcitatory Milieu of the Hypothalamic Paraventricular Nucleus.Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth.Immunotherapy for cardiovascular disease.Work-related stress as a cardiovascular risk factor in police officers: a systematic review of evidence.A Review of Interleukin-1 in Heart Disease: Where Do We Stand Today?ASC Methylation and Interleukin-1β Are Associated with Aerobic Capacity in Heart Failure.Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers.
P2860
Q26778539-DF18D516-7203-479E-9B3E-A569A1A052B2Q36022217-FAB5A821-D3BA-4AE0-ACB1-D1FACE2372B6Q37734346-9231A4C1-58B6-44C1-8F90-72AF713DEA31Q38851472-BA764727-6C81-4B2A-B8BD-3BD3ACA046E1Q39386445-62639418-7391-4830-99D0-9CDB43E19EF9Q40815110-E937D250-30BD-4FA6-8D43-C08EB37B0179Q45058507-1A409711-92EC-4568-8A47-6C59D669C318Q45068688-CEF3E911-CCD4-4A20-B126-DC80373389EFQ45073053-3DCCB3A6-39F5-4A0F-937A-1249461B5F4FQ47288476-C93F76F2-6160-4156-96B6-73D6D62BE1BDQ47699200-6EEB8A9C-7ED6-4371-B330-E28BE7FD2BD3Q47713533-21FA8EBE-6C33-4FD6-82CE-D0BF3CA58FB5Q48532758-5DE87656-5659-4648-A2A1-8F982CFE3988Q49981164-D1673B91-00A1-47C1-B94A-A7D4771744A9Q50125894-C386F137-D53F-405F-85C6-6A1372B954A3Q51202602-1C1B61DE-D7E3-47CA-AA43-0951517C4864Q55155611-4363B080-7EDD-40C6-ABD5-4DD94E54D14C
P2860
Targeting interleukin-1 in heart failure and inflammatory heart disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeting interleukin-1 in heart failure and inflammatory heart disease.
@en
type
label
Targeting interleukin-1 in heart failure and inflammatory heart disease.
@en
prefLabel
Targeting interleukin-1 in heart failure and inflammatory heart disease.
@en
P2093
P2860
P921
P1476
Targeting interleukin-1 in heart failure and inflammatory heart disease.
@en
P2093
Antonio Abbate
Benjamin W Van Tassell
Juan M Valle Raleigh
P2860
P2888
P356
10.1007/S11897-014-0231-7
P577
2015-02-01T00:00:00Z
P6179
1019378698